DE60230593D1 - Peptidgerüstverkapselung von gewebszellen und verwendungen davon - Google Patents

Peptidgerüstverkapselung von gewebszellen und verwendungen davon

Info

Publication number
DE60230593D1
DE60230593D1 DE60230593T DE60230593T DE60230593D1 DE 60230593 D1 DE60230593 D1 DE 60230593D1 DE 60230593 T DE60230593 T DE 60230593T DE 60230593 T DE60230593 T DE 60230593T DE 60230593 D1 DE60230593 D1 DE 60230593D1
Authority
DE
Germany
Prior art keywords
cells
vitro
transdifferentiation
differentiation
provides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60230593T
Other languages
English (en)
Inventor
John Kisiday
Alan J Grodzinsky
Shuguang Zhang
James Sherley
Carlos Semino
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Massachusetts Institute of Technology
Original Assignee
Massachusetts Institute of Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/778,200 external-priority patent/US7449180B2/en
Application filed by Massachusetts Institute of Technology filed Critical Massachusetts Institute of Technology
Application granted granted Critical
Publication of DE60230593D1 publication Critical patent/DE60230593D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0655—Chondrocytes; Cartilage
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0012—Cell encapsulation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/067—Hepatocytes
    • C12N5/0672—Stem cells; Progenitor cells; Precursor cells; Oval cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/05—Inorganic components
    • C12N2500/10—Metals; Metal chelators
    • C12N2500/20—Transition metals
    • C12N2500/24—Iron; Fe chelators; Transferrin
    • C12N2500/25—Insulin-transferrin; Insulin-transferrin-selenium
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/11—Epidermal growth factor [EGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/13—Nerve growth factor [NGF]; Brain-derived neurotrophic factor [BDNF]; Cilliary neurotrophic factor [CNTF]; Glial-derived neurotrophic factor [GDNF]; Neurotrophins [NT]; Neuregulins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/13—Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
    • C12N2502/1317—Chondrocytes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/30—Synthetic polymers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/50—Proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Rheumatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
DE60230593T 2001-02-06 2002-02-06 Peptidgerüstverkapselung von gewebszellen und verwendungen davon Expired - Lifetime DE60230593D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/778,200 US7449180B2 (en) 2001-02-06 2001-02-06 Macroscopic scaffold containing amphiphilic peptides encapsulating cells
US30537901P 2001-07-13 2001-07-13
PCT/US2002/003482 WO2002062961A2 (en) 2001-02-06 2002-02-06 Peptide scaffold encapsulation of tissue cells and uses thereof

Publications (1)

Publication Number Publication Date
DE60230593D1 true DE60230593D1 (de) 2009-02-12

Family

ID=26974566

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60230593T Expired - Lifetime DE60230593D1 (de) 2001-02-06 2002-02-06 Peptidgerüstverkapselung von gewebszellen und verwendungen davon

Country Status (5)

Country Link
EP (1) EP1367961B1 (de)
JP (2) JP5057629B2 (de)
AT (1) ATE419333T1 (de)
DE (1) DE60230593D1 (de)
WO (2) WO2002062961A2 (de)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2731314C1 (ru) * 2019-10-30 2020-09-01 Общество С Ограниченной Ответственностью "Международный Центр Медицинских Исследований И Разработок" (Ооо "Мц Миир") Способ производства клеточных сфероидов для восстановления хрящей
RU2750021C1 (ru) * 2020-08-26 2021-06-21 Общество С Ограниченной Ответственностью "Международный Центр Медицинских Исследований И Разработок" (Ооо "Мц Миир") Способ восстановления диафизов длинных трубчатых костей с применением клеточных технологий

Families Citing this family (93)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1414944A4 (de) * 2001-07-10 2004-09-15 Massachusetts Inst Technology Verfahren zur ex-vivo-vermehrung somatischer stammzellen
US7491690B2 (en) 2001-11-14 2009-02-17 Northwestern University Self-assembly and mineralization of peptide-amphiphile nanofibers
US7645610B2 (en) 2002-02-15 2010-01-12 Massachusetts Institute Of Technology Hepatocyte precursor cell lines
WO2003070749A2 (en) 2002-02-15 2003-08-28 Northwestern University Self-assembly of peptide-amphiphile nanofibers under physiological conditions
AU2003262760A1 (en) 2002-08-21 2004-03-11 Northwestern University Charged peptide-amphiphile solutions and self-assembled peptide nanofiber networks formed therefrom
US7554021B2 (en) 2002-11-12 2009-06-30 Northwestern University Composition and method for self-assembly and mineralization of peptide amphiphiles
US7683025B2 (en) 2002-11-14 2010-03-23 Northwestern University Synthesis and self-assembly of ABC triblock bola peptide amphiphiles
US7390526B2 (en) 2003-02-11 2008-06-24 Northwestern University Methods and materials for nanocrystalline surface coatings and attachment of peptide amphiphile nanofibers thereon
DK1636250T3 (en) * 2003-06-25 2016-02-22 Massachusetts Inst Technology SELF-ORGANIZING PEPTIDES, CONTAINING MODIFICATIONS, AND APPLICATIONS THEREOF
US7713923B2 (en) 2003-06-25 2010-05-11 Massachusetts Institute Of Technology Self-assembling peptides incorporating modifications and methods of use thereof
US9572840B2 (en) 2003-06-27 2017-02-21 DePuy Synthes Products, Inc. Regeneration and repair of neural tissue using postpartum-derived cells
US7875272B2 (en) 2003-06-27 2011-01-25 Ethicon, Incorporated Treatment of stroke and other acute neuraldegenerative disorders using postpartum derived cells
US9592258B2 (en) 2003-06-27 2017-03-14 DePuy Synthes Products, Inc. Treatment of neurological injury by administration of human umbilical cord tissue-derived cells
US8491883B2 (en) 2003-06-27 2013-07-23 Advanced Technologies And Regenerative Medicine, Llc Treatment of amyotrophic lateral sclerosis using umbilical derived cells
AU2004252570C1 (en) 2003-06-27 2012-03-01 Ethicon, Incorporated Soft tissue repair and regeneration using postpartum-derived cells
US8790637B2 (en) 2003-06-27 2014-07-29 DePuy Synthes Products, LLC Repair and regeneration of ocular tissue using postpartum-derived cells
CA2457296A1 (en) 2003-08-19 2005-02-19 Takahiro Ochiya Methods for inducing differentiation of pluripotent cells
US20050053586A1 (en) * 2003-09-04 2005-03-10 Bryan Conn Entrapped stem cells and uses thereof
EP1670493A4 (de) * 2003-10-10 2007-10-24 Transform Pharmaceuticals Inc In vitro-entwicklung von geweben und organen
US7704740B2 (en) 2003-11-05 2010-04-27 Michigan State University Nanofibrillar structure and applications including cell and tissue culture
CN1905893A (zh) 2003-12-05 2007-01-31 西北大学 分支的肽两亲物、相关的表位组合物和其自组装的结构
MXPA06006388A (es) 2003-12-05 2006-09-04 Univ Northwestern Peptidos anfifilicos de auto-ensamble y metodos relacionados para el suministro del factor de crecimiento.
US7655465B2 (en) 2004-06-07 2010-02-02 Massachusetts Institute Of Technology Methods for ex vivo propagation of somatic hair follicle stem cells
GB0415080D0 (en) * 2004-07-05 2004-08-04 Ucl Biomedica Plc Methods for preparing tissue equivalent implants and products thereof
WO2006014570A2 (en) * 2004-07-06 2006-02-09 3D Matrix, Inc. Purified amphilic peptide compositions and uses thereof
US8039258B2 (en) 2004-09-28 2011-10-18 Ethicon, Inc. Tissue-engineering scaffolds containing self-assembled-peptide hydrogels
US20060069008A1 (en) 2004-09-28 2006-03-30 Sanjay Mistry Treatment of neurological deficits in the striatum or substanta nigra pars compacta
EP1833496B1 (de) 2004-12-23 2013-07-31 Ethicon, Incorporated Behandlung von schlaganfall und anderer akuter degenerativer nervenerkrankungen mit post partum erhaltenen zellen
US7429567B2 (en) * 2005-01-04 2008-09-30 The Brigham And Women's Hospital, Inc. Sustained delivery of PDGF using self-assembling peptide nanofibers
US20060247165A1 (en) * 2005-01-21 2006-11-02 Stupp Samuel I Methods and compositions for encapsulation of cells
CN101184995A (zh) 2005-03-04 2008-05-21 西北大学 生血管肝素结合肽两亲物
ES2427565T3 (es) 2005-04-25 2013-10-31 Massachusetts Institute Of Technology Péptidos autoensambladores para promover la hemostasia
US9162005B2 (en) 2005-04-25 2015-10-20 Arch Biosurgery, Inc. Compositions for prevention of adhesions and other barrier applications
AU2011253661B2 (en) * 2005-04-26 2013-06-13 Boehringer Ingelheim Rcv Gmbh & Co Kg Production of recombinant proteins by autoproteolytic cleavage of a fusion protein
CN103333252A (zh) * 2005-04-26 2013-10-02 桑多斯股份公司 通过融合蛋白的自我蛋白剪切制备重组蛋白
JP2006346420A (ja) * 2005-06-13 2006-12-28 Univ Nagoya 移植材料及び骨質改善剤
WO2007002228A1 (en) * 2005-06-23 2007-01-04 Massachusetts Institute Of Technology Methods for ex vivo propagation of adult hepatic stem cells
US8299032B2 (en) 2005-06-27 2012-10-30 Menicon Co., Ltd. Self-assembling peptide and gel produced from the same
JP2007039394A (ja) * 2005-08-04 2007-02-15 Nippon Menaade Keshohin Kk 老化予防改善皮膚外用剤
JP5263756B2 (ja) * 2005-09-30 2013-08-14 国立大学法人 岡山大学 細胞の培養方法および細胞培養物
JP4982841B2 (ja) * 2005-10-12 2012-07-25 国立大学法人名古屋大学 再生医療骨組成物
CN101374946B (zh) 2005-12-16 2017-07-18 伊西康公司 用于在组织相容性不匹配的移植中抑制有害的免疫反应的组合物和方法
US9125906B2 (en) 2005-12-28 2015-09-08 DePuy Synthes Products, Inc. Treatment of peripheral vascular disease using umbilical cord tissue-derived cells
JP2007217375A (ja) * 2006-02-17 2007-08-30 Nagoya Institute Of Technology 自己組織化ペプチド
JP2007217376A (ja) * 2006-02-17 2007-08-30 Nagoya Institute Of Technology 自己組織化ペプチド組成物
HUE037994T2 (hu) 2006-04-25 2018-09-28 Massachusetts Inst Technology Készítmények és eljárások szennyezõ anyagok, testfolyadékok vagy más anyagok mozgásának befolyásolására és/vagy más fiziológiai állapotok befolyásolására
EP2860194B1 (de) * 2006-09-26 2018-11-07 Massachusetts Institute Of Technology Modifizierte selbstanordnende Peptide
DE102007006843A1 (de) 2007-02-12 2008-08-14 Bioregeneration Gmbh Verfahren und Stützstruktur zum Kultivieren lebender Zellen
EP2146733B1 (de) * 2007-03-14 2020-11-25 Arch Biosurgery, Inc. Behandlung von leckenden oder beschädigten engen verbindungen und verstärkung der extrazellulären matrix
US8076295B2 (en) 2007-04-17 2011-12-13 Nanotope, Inc. Peptide amphiphiles having improved solubility and methods of using same
KR101507188B1 (ko) 2007-06-27 2015-03-30 더 보드 어브 트러스티스 어브 더 리랜드 스탠포드 주니어 유니버시티 펩티드 티로시나제 억제제 및 그의 용도
WO2009072556A1 (ja) * 2007-12-05 2009-06-11 3-D Matrix, Ltd. 創傷治癒・皮膚再建材
ATE555191T1 (de) 2008-01-30 2012-05-15 Geron Corp Synthetische oberflächen zur kultivierung von zellen in chemisch definierten medien
EP2240536B1 (de) 2008-01-30 2019-09-04 Asterias Biotherapeutics, Inc. Synthetische oberflächen zur kultivierung von oligodendrozyten-vorläuferzellen aus stammzellen
CA2712891A1 (en) 2008-01-30 2009-08-06 Corning Incorporated Synthetic surfaces for culturing stem cell derived cardiomyocytes
US8329469B2 (en) 2008-01-30 2012-12-11 Geron Corporation Swellable (meth)acrylate surfaces for culturing cells in chemically defined media
ES2694000T3 (es) 2008-10-06 2018-12-17 3-D Matrix Ltd. Tapón de tejido
US10179900B2 (en) 2008-12-19 2019-01-15 DePuy Synthes Products, Inc. Conditioned media and methods of making a conditioned media
US20130302283A1 (en) 2012-05-14 2013-11-14 Advanced Technologies And Regenerative Medicine, Llc hUTC MODULATION OF PRO-INFLAMMATORY MEDIATORS OF LUNG AND PULMONARY DISEASES AND DISORDERS
BRPI0923068B1 (pt) 2008-12-19 2021-05-25 Advanced Technologies And Regenerative Medicine, Llc Uso de células derivadas de tecido de cordão umbilical para tratar um paciente tendo uma doença, distúrbio ou injúria pulmonar
WO2010071862A1 (en) 2008-12-19 2010-06-24 Ethicon, Incorporated Umbilical cord tissue derived cells for treating neuropathic pain and spasticity
CN102498204B (zh) 2009-03-26 2015-02-04 德普伊新特斯产品有限责任公司 人脐带组织细胞作为用于阿尔茨海默病的疗法
KR20120012811A (ko) 2009-04-13 2012-02-10 노오쓰웨스턴 유니버시티 신규한 연골 재생용 펩티드-기반 스카폴드 및 이들의 사용 방법
US8362144B2 (en) 2009-05-21 2013-01-29 Corning Incorporated Monomers for making polymeric cell culture surface
US9084752B2 (en) * 2009-12-14 2015-07-21 The University Of Hong Kong Compositions and methods for controlling proliferation and differentiation of cells
US9439941B2 (en) 2009-12-14 2016-09-13 The University Of Hong Kong Nano cancer barrier device (NCBD) to immobilize and inhibit the division of metastic cancer stem cells
JP5732691B2 (ja) * 2010-01-14 2015-06-10 学校法人同志社 インスリン製剤
EP2552938B1 (de) * 2010-03-31 2016-03-02 Agency for Science, Technology And Research Amphiphiles lineares peptid/peptoid und hydrogel damit
KR101029705B1 (ko) * 2010-06-30 2011-04-18 (주)엔솔테크 신규 펩타이드 및 그 용도
JP2013538864A (ja) * 2010-10-08 2013-10-17 ソルヴェイ（ソシエテ アノニム） 生物活性アミノ酸配列及びその使用
JP2012082180A (ja) * 2010-10-14 2012-04-26 Nagoya Univ 骨再生用自己組織化ペプチドハイドロゲル
WO2012162637A2 (en) 2011-05-26 2012-11-29 Kansas State University Research Foundation Vaccine adjuvants from self-assembling peptides
JP5937210B2 (ja) 2011-08-10 2016-06-22 デピュイ・シンセス・プロダクツ・インコーポレイテッド 臍帯組織由来細胞を用いた末梢血管疾患の治療
US9611513B2 (en) 2011-12-23 2017-04-04 DePuy Synthes Products, Inc. Detection of human umbilical cord tissue derived cells
GB201203085D0 (en) 2012-02-22 2012-04-04 Univ Manchester Hydrogels
CN102718841B (zh) * 2012-06-27 2013-11-13 深圳翰宇药业股份有限公司 一种肽生物材料的纯化方法
WO2014008400A2 (en) 2012-07-06 2014-01-09 3-D Matrix, Inc. Fill-finish process for peptide solutions
CA2886109A1 (en) * 2012-12-07 2014-06-12 Kansas State University Research Foundation Peptide-albumin hydrogel properties and its applications
KR101501436B1 (ko) 2013-02-14 2015-03-18 주식회사 나이벡 생리활성 펩타이드가 자기회합된 젤 형태의 지지체 및 그 제조방법
EP3035974B1 (de) 2013-08-22 2019-10-09 Arch Biosurgery Inc. Implantierbare netze zur steuerung der bewegung von fluiden
ES2711728T3 (es) 2014-03-10 2019-05-07 3 D Matrix Ltd Composiciones de péptidos de autoensamblaje
US10245299B2 (en) 2014-03-10 2019-04-02 3-D Matrix, Ltd. Autoassembling peptides for the treatment of pulmonary bulla
US10369237B2 (en) 2014-03-10 2019-08-06 3-D Matrix, Ltd. Sterilization and filtration of peptide compositions
DE102015000363A1 (de) 2015-01-20 2016-07-21 Emc Microcollections Gmbh Neue modular funktionalisierbare Peptid-Hydrogele
CN104650192B (zh) * 2015-03-26 2017-06-23 罗忠礼 一类能用于修复子宫和保护心肌的自组装短肽及其应用
CN105148289B (zh) * 2015-09-30 2018-10-09 南京中医药大学 一种两亲性寡聚多肽药物结合物
WO2017120092A1 (en) 2016-01-06 2017-07-13 3-D Matrix, Ltd. Combination compositions
KR20200018506A (ko) * 2017-05-29 2020-02-19 오르제네시스 엘티디. 세포 대체 요법을 제공하기 위한 조성물 및 방법
CN107446897A (zh) * 2017-08-09 2017-12-08 国家海洋局第三海洋研究所 一种鱼肝脏粗酶液冻干粉及其制备方法
CN111712230B (zh) 2017-12-15 2024-04-26 立美基股份有限公司 表面活性剂肽纳米结构及在药物递送中的用途
WO2020171161A1 (ja) * 2019-02-20 2020-08-27 国立大学法人東京農工大学 自己組織化ペプチド
EP4229179A1 (de) * 2020-10-15 2023-08-23 Katholieke Universiteit Leuven, KU Leuven R&D Kugelförmige selbstangeordnete peptidhydrogele mit zellen
WO2022236187A1 (en) 2021-05-07 2022-11-10 Children's Hospital Los Angeles Methods for making stem cell-derived enteric neural crest cells and their use in enteric neuropathy treatment

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5670483A (en) * 1992-12-28 1997-09-23 Massachusetts Insititute Of Technology Stable macroscopic membranes formed by self-assembly of amphiphilic peptides and uses therefor
US5955343A (en) * 1992-12-28 1999-09-21 Massachusetts Institute Of Technology Stable macroscopic membranes formed by self-assembly of amphiphilic peptides and uses therefor
US5834029A (en) * 1994-07-20 1998-11-10 Cytotherapeutics, Inc. Nerve guidance channel containing bioartificial three-dimensional hydrogel extracellular matrix derivatized with cell adhesive peptide fragment
US6129761A (en) * 1995-06-07 2000-10-10 Reprogenesis, Inc. Injectable hydrogel compositions
DK0981381T3 (da) * 1997-05-12 2007-06-04 Metabolix Inc Polyhydroxyalkanoater ti anvendelser in vivo
US6368877B1 (en) * 1997-06-25 2002-04-09 Massachusetts Institute Of Technology Self-assembling peptide surfaces for cell patterning and interactions

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2731314C1 (ru) * 2019-10-30 2020-09-01 Общество С Ограниченной Ответственностью "Международный Центр Медицинских Исследований И Разработок" (Ооо "Мц Миир") Способ производства клеточных сфероидов для восстановления хрящей
RU2750021C1 (ru) * 2020-08-26 2021-06-21 Общество С Ограниченной Ответственностью "Международный Центр Медицинских Исследований И Разработок" (Ооо "Мц Миир") Способ восстановления диафизов длинных трубчатых костей с применением клеточных технологий

Also Published As

Publication number Publication date
JP2005515796A (ja) 2005-06-02
WO2002062969A3 (en) 2002-11-28
WO2002062969A9 (en) 2002-10-17
ATE419333T1 (de) 2009-01-15
WO2002062961A9 (en) 2002-10-31
EP1367961A4 (de) 2004-07-21
JP2010069330A (ja) 2010-04-02
WO2002062961A3 (en) 2003-07-24
EP1367961A2 (de) 2003-12-10
WO2002062961A2 (en) 2002-08-15
WO2002062969A2 (en) 2002-08-15
JP5057629B2 (ja) 2012-10-24
EP1367961B1 (de) 2008-12-31

Similar Documents

Publication Publication Date Title
DE60230593D1 (de) Peptidgerüstverkapselung von gewebszellen und verwendungen davon
WO2004007683A3 (en) Cellular reprogramming in peptide hydrogel and uses thereof
Nahmias et al. Laser‐guided direct writing for three‐dimensional tissue engineering
US11926848B2 (en) Stromal stem cells
JP7196216B2 (ja) 改善された幹細胞組成物
Martinez Saez et al. Stem cells from human exfoliated deciduous teeth: a growing literature
Tachibana et al. Rapid fabrication of keratin–hydroxyapatite hybrid sponges toward osteoblast cultivation and differentiation
ES2654428T3 (es) Aislamiento de células multipotenciales adultas por fosfatasa alcalina no específica de tejido
Pravdyuk et al. Cryopreservation of alginate encapsulated mesenchymal stromal cells
Zhang et al. Osteogenic properties of hydrophilic and hydrophobic titanium surfaces evaluated with osteoblast-like cells (MG63) in coculture with human umbilical vein endothelial cells (HUVEC)
US20120107413A1 (en) Pre-natal mesenchymal stem cells
US20060140914A1 (en) Repairing or replacing tissues or organs
CN104894064A (zh) 一种用于培养间充质干细胞的培养基
Manfrini et al. Mesenchymal stem cells from patients to assay bone graft substitutes
KR20090109127A (ko) 부착성 태반 줄기세포에서 유래한 간세포와 연골세포 및 ｃｄ34＋, ｃｄ45－ 태반 줄기세포가 농축된 세포군
EP1165830A4 (de) Aus fettgewebe stammende stammzellen und gitter
RU2742828C2 (ru) Применение стволовых клеток, экспрессирующих мезенхимальные и нейрональные маркеры, и их композиций для лечения неврологических заболеваний (варианты)
Kim et al. Evaluation of the periodontal regenerative properties of patterned human periodontal ligament stem cell sheets
Fu et al. Laminin-modified dental pulp extracellular matrix for dental pulp regeneration
ES2580377T3 (es) Método para cultivar células en un medio que contiene lisado de plaquetas
Zou et al. Microscale roughness regulates laminin-5 secretion of bone marrow mesenchymal stem cells
ITFI20060099A1 (it) Popolazione di cellule staminali renali, sua identificazione ed uso per finalita' terapeutiche
Varaa et al. Ameliorating effect of encapsulated hepatocyte-like cells derived from umbilical cord in high mannuronic alginate scaffolds on acute liver failure in rats
ITUB20159750A1 (it) Metodo per la promozione ed il miglioramento delle proprieta? del tessuto adiposo, tessuto e cellule ottenute tramite detto metodo
TR201809635T4 (tr) Osteoblastik fonksiyonun arttırılmasına yönelik yöntemler.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition